FactaeThe Factual News

Top Stories Focus Media

🌍Monde
France
🏛️Politique
🪖Guerre
🚨Défense & Sécurité

💰Économie
📈Marchés
⚡Énergie
💹Crypto

📱Tech
🤖Intelligence artificielle
💻Informatique
🛡️Cybersécurité

🔬Science
🏥Santé
🌿Écologie

📖Histoire
🏅Sport
🖼️Culture
⚖️Droit
🎓Éducation

Factae

The Factual News

The intelligence of the news. Multi-source, geolocated, synthesized.

Live

Live feed Scoops Immersive map

Explore

Trading Board Trends AI models AI for developers Sources

Information

About Methodology RSS feed Contact Terms Privacy Legal Newsletter

© 2026 Factae. All rights reserved.

Abivax under scrutiny following movements on the Nasdaq | Factae

Home/📈 marches

📈

Abivax under scrutiny following movements on the Nasdaq

Investors question recent fluctuations of Abivax on the Nasdaq.

Published 1sem·1 sourceNotable·updated 1sem

Lire en français

≈ 13sSpeed

The fact

Online discussions mention potential sales by key shareholders.

The stock remains volatile amid expected clinical results.

🔗Click the link to read an article on the topic:

📈

🧭Explore this topic

📍Paris 📍France 🏢Abivax #Abivax #Nasdaq #Bourse #volatilité

What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.→

LondresWorld map →

Follow topic →

Auto-synthesis from 1 media source · identified on July 6, 2026

← Back to home

Discover

Read more

All marches →

Abivax: stock volatility and clinical trial questions

6sem · 1 source 📈marches

Abivax collapses on Nasdaq with 44 percent decline

6sem · 1 source 📈marches

Abivax discussed on forums following US reactions

1sem · 1 source 📈marches

Abivax in spotlight after unusual $120.88 transaction

3sem · 1 source 📈marches30 %

Abivax plunges on stock market after safety concerns emerge on treatment

6sem · 1 source 📈marches7.36 million

Abivax issues 7.36 million American Depositary Shares

1sem · 1 source